ERAS ▼ -12.2% - Erasca, Inc.
$ERAS - Erasca Reports Broad and Robust Phase 1 Clinical Efficacy and Favorable Safety Data for Pan-RAS Molecular Glue ERAS-0015
20-NOV-2026 07:00 AM ET
Share this post
More filings for $ERAS
ERAS ▼ -8.1% - Erasca, Inc.Nov 17, 2026ERAS - Erasca, Inc. - SEC Filing Update (16-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 16, 2026ERAS - Erasca, Inc. - SEC Filing Update (16-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 16, 2026ERAS ▼ -2.0% - Erasca, Inc.Nov 16, 2026ERAS ▼ -6.1% - Erasca, Inc.Nov 12, 2026ERAS ▼ -6.1% - Erasca, Inc.Nov 12, 2026
View full $ERAS filing history →💬 Comments
Loading comments…
Leave a comment
